National Health Investors Inc. (NYSE:NHI) has been assigned a consensus rating of “Hold” from the nine ratings firms that are currently covering the firm. Six analysts have rated the stock with a hold recommendation and three have assigned a buy recommendation to the company. The average 1-year price objective among brokerages that have issued ratings on the stock in the last year is $72.60.
Several equities research analysts recently issued reports on the stock. JMP Securities reaffirmed a “hold” rating on shares of National Health Investors in a report on Saturday, June 4th. Wells Fargo & Co. reaffirmed a “hold” rating on shares of National Health Investors in a report on Sunday, September 4th. Zacks Investment Research upgraded shares of National Health Investors from a “sell” rating to a “hold” rating in a research report on Thursday, August 11th. Mizuho boosted their price target on shares of National Health Investors from $66.00 to $77.00 and gave the stock a “neutral” rating in a research report on Monday, August 8th. Finally, Stephens began coverage on shares of National Health Investors in a research report on Wednesday, September 14th. They issued an “overweight” rating and a $84.00 price target on the stock.
Shares of National Health Investors (NYSE:NHI) traded down 0.58% during midday trading on Tuesday, hitting $80.02. 136,205 shares of the stock traded hands. The stock has a market capitalization of $3.13 billion, a P/E ratio of 18.45 and a beta of 0.65. The firm has a 50-day moving average price of $79.72 and a 200-day moving average price of $72.97. National Health Investors has a 52 week low of $54.51 and a 52 week high of $82.53.
National Health Investors (NYSE:NHI) last announced its quarterly earnings results on Friday, August 5th. The real estate investment trust reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.21 by $0.01. The company had revenue of $61.20 million for the quarter, compared to analyst estimates of $58.08 million. National Health Investors had a net margin of 69.69% and a return on equity of 14.68%. The firm’s revenue was up 8.7% on a year-over-year basis. During the same period in the previous year, the firm posted $1.17 EPS. On average, equities analysts predict that National Health Investors will post $4.88 earnings per share for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 10th. Stockholders of record on Friday, September 30th will be paid a $0.90 dividend. The ex-dividend date is Wednesday, September 28th. This represents a $3.60 annualized dividend and a dividend yield of 4.47%. National Health Investors’s dividend payout ratio is currently 82.95%.
In other news, insider Kristin Sallee Gaines sold 8,652 shares of National Health Investors stock in a transaction on Wednesday, June 29th. The shares were sold at an average price of $73.98, for a total value of $640,074.96. Following the completion of the sale, the insider now owns 53,089 shares in the company, valued at approximately $3,927,524.22. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Robert A. Mccabe, Jr. sold 800 shares of National Health Investors stock in a transaction on Tuesday, August 30th. The shares were sold at an average price of $80.29, for a total transaction of $64,232.00. Following the completion of the sale, the director now owns 10,021 shares of the company’s stock, valued at approximately $804,586.09. The disclosure for this sale can be found here. 5.74% of the stock is currently owned by insiders.
Hedge funds have recently added to or reduced their stakes in the stock. State Street Corp raised its stake in shares of National Health Investors by 4.7% in the first quarter. State Street Corp now owns 722,413 shares of the real estate investment trust’s stock worth $48,056,000 after buying an additional 32,283 shares during the period. Bayesian Capital Management LP acquired a new stake in shares of National Health Investors during the first quarter worth approximately $269,000. Aperio Group LLC acquired a new stake in shares of National Health Investors during the first quarter worth approximately $263,000. Adams Diversified Equity Fund Inc. acquired a new stake in shares of National Health Investors during the second quarter worth approximately $466,000. Finally, BlackRock Japan Co. Ltd raised its stake in shares of National Health Investors by 1.1% in the first quarter. BlackRock Japan Co. Ltd now owns 1,809 shares of the real estate investment trust’s stock worth $120,000 after buying an additional 20 shares during the period. Institutional investors own 67.49% of the company’s stock.
About National Health Investors
National Health Investors, Inc is a self-managed real estate investment trust (REIT) specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. The Company is engaged in the business of owning and financing healthcare properties.
Receive News & Ratings for National Health Investors Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors Inc. and related companies with MarketBeat.com's FREE daily email newsletter.